Investment Targets We make strategic investments in privately owned biotechnology companies focused on discovering and developing human therapeutics. Aimed at reinforcement of Astellas Pharma’s assets, we look for companies which have potential to become Astellas Pharma’s collaboration partners in R&D through our investment activities.
Therapeutic Areas of Focus The disease fields of our interest are basically in line with the current strategy of Astellas Pharma. We also seek out breakthrough technologies that may provide the opportunity to advance the creation of human therapeutics in the above related fields.
Investment Stage We have an interest in relatively early-stage biotechnology companies that have not yet begun testing their products in clinical trials as well as have programs at very early stages of clinical trials.
What AVM Provides The strength of AVM lies in our “Pharma View” based on our long-standing experiences in the pharmaceutical industry. By providing our portfolio companies with invaluable information including the landscape of the market in Japan, we are able to support their growth. Moreover, we can create value for the portfolio companies by facilitating a dialog with Astellas Pharma, which in turn paves the way for future collaborations.